Proliferation assessed at 24 h post treatment using ki67 staining also showed a trend to a decrease in all groups but never reached significance, suggesting that additional mechanisms account for tumor growth delay in response to BRAF/MEK inhibition in YUMM1.7 xenografts. Here, BRAF is linked to neoplasm.